Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic Network Analysis-Reference-Cited by-同舟云学术

Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT1b) Using Molecular Dynamics Simulations and Dynamic Network Analysis

Published:2020-02-20 Issue:3 Volume:60 Page:1749-1765
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Sullivan Holli-Joi¹,Tursi Amanda¹,Moore Kelly¹,Campbell Alexandra¹,Floyd Cecilia¹,Wu Chun¹^ORCID

Affiliation:

1. College of Science and Mathematics, Rowan University, Glassboro, New Jersey 08028 United States

Funder

National Science Foundation

College of Science and Mathematics, Rowan University

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.9b01082

Reference83 articles.

1. Application Strategies for the Primary Structure–Activity Relationship Exploration

2. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets

3. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans

4. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity;Molecular Neurobiology;2024-08-12

2. Computational drug repurposing effort for identifying novel hits for the treatment of diseases such as endometriosis, uterine fibroids, and prostate cancer;Turkish Journal of Chemistry;2024-04-25

3. Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies;RSC Medicinal Chemistry;2024

4. New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay;Frontiers in Neurology;2023-11-21

5. Molecular Biomechanics of the TAS2R46 Bitter Taste Receptor through Network-based Investigation;2023-11-21